Medication-assisted Treatment Research with Criminal Justice Populations: Challenges of Implementation
Medication-assisted Treatment Research with Criminal Justice Populations: Challenges of Implementation
复制标题
DOI：
10.1002/bsl.1015
复制
发表时间：
2011-11-01
影响因子：
1.4
通讯作者：
Miller, Patrice M.
中科院分区：
文献类型：
--
作者：
Gordon, Michael S.;Kinlock, Timothy W.;Miller, Patrice M.
为有海洛因成瘾史的囚犯、假释犯和缓刑人员创建、实施和评估药物滥用干预措施，特别是药物辅助治疗，是一项特别具有挑战性的工作，因为很难协调和实现不同刑事司法、药物滥用治疗、研究和社会服务机构之间的合作，每个机构都有自己的优先事项和议程。此外，在对涉及刑事司法的人群，特别是囚犯进行研究时，还必须遵守一些特殊规则。以下案例研究将探索作者10多年来在刑事司法人群中使用美沙酮、丁丙诺啡和纳曲酮进行药物治疗研究的经验。介绍了主要的障碍以及如何克服这些障碍。最后，就实施和开展刑事司法人员研究提出了建议。版权所有(C)2011 John Wiley&Sons，Ltd.
Creating, implementing and evaluating substance abuse interventions, especially medication-assisted treatments, for prisoners, parolees, and probationers with histories of heroin addiction is an especially challenging endeavor because of the difficulty in coordinating and achieving cooperation among diverse criminal justice, substance abuse treatment, research, and social service agencies, each with its own priorities and agenda. In addition, there are special rules that must be followed when conducting research with criminal justice-involved populations, particularly prisoners. The following case studies will explore the authors' experience of over 10?years conducting pharmacotherapy research using methadone, buprenorphine, and naltrexone with criminal justice populations. The major obstacles and how they were overcome are presented. Finally, recommendations are provided with regard to implementing and conducting research with criminal justice populations. Copyright (c) 2011 John Wiley & Sons, Ltd.